Skip to main navigation Skip to search Skip to main content

Dlk1 in normal and abnormal hematopoiesis

  • S. Sakajiri
  • , J. O'Kelly
  • , D. Yin
  • , C. W. Miller
  • , W. K. Hofmann
  • , K. Oshimi
  • , L. Y. Shih
  • , K. H. Kim
  • , H. S. Sul
  • , C. H. Jensen
  • , B. Teisner
  • , Norihiko Kawamata*
  • , H. P. Koeffler
  • *Corresponding author for this work
  • University of California at Los Angeles
  • Goethe University Frankfurt
  • Juntendo University
  • University of California at Berkeley
  • University of Southern Denmark

Research output: Contribution to journalJournal Article peer-review

82 Scopus citations

Abstract

Dlk1 (Pref-1) is a transmembrane and secreted protein, which is a member of the epidermal growth factor-like family, homologous to Notch/Delta/Serrate. We have found by real-time RT-PCR that Dlk1 mRNA levels were high in CD34+ cells in 10 of 12 MDS samples compared with CD34+ cells from 11 normals. Also, Dlk1 mRNA was elevated in mononuclear, low density bone marrow cells from 11/38 MDS patients, 5/11 AML M6 and 2/4 AML M7 samples. Furthermore, 5/6 erythroleukemia and 2/2 megakaryocytic leukemia cell lines highly expressed Dlk1 mRNA. Levels of Dlk1 mRNA markedly increased during megakaryocytic differentiation of both CMK megakaryoblasts as well as normal CD34+ hematopoietic stem cells. High serum levels of Dlk1 occurred in RA (4/10) and essential thrombocythemia (2/10) patients. Functional studies showed that forced expression of Dlk1 enhanced proliferation of K562 cells growing in 1% fetal bovine serum. Analysis of hematopoiesis of Dlk1 knockout mice suggested that Dlk1 contributed to granulocyte, megakaryocyte and B-cell clonogenic growth and was needed for generation of splenic B-cells. In summary, Dlk1 is overexpressed in selected samples of MDS (especially RA and RAEB) and AML (particularly M6, M7), and it appears to be associated with normal development of megakaryocytes and B cells.

Original languageEnglish
Pages (from-to)1404-1410
Number of pages7
JournalLeukemia
Volume19
Issue number8
DOIs
StatePublished - 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • B-cell development
  • Erythroleukemia
  • MDS
  • Megakaryocyte
  • Real-time PCR

Fingerprint

Dive into the research topics of 'Dlk1 in normal and abnormal hematopoiesis'. Together they form a unique fingerprint.

Cite this